Loading clinical trials...
Loading clinical trials...
Effect of Daily Remote Ischemic Conditioning on the Life Quality of Refractory Angina Pectoris Patients and the Mechanism
The purpose is to test whether daily ischemic conditioning of the arms over 30 days could reduce the frequency and severity of angina pectoris and improve the life quality of refractory angina pectoris patients.
Refractory angina pectoris denotes "chronic stable angina that persists despite optimal medication and when revascularisation is unfeasible or where the risks are unjustified". These patients could potentially be relieved by non-conventional treatments like remote ischemic conditioning, and actually this effect has been observed in several cases in the center of the sponsor. This study is a pilot study to measure the efficacy and safety of this method in this group of patients.
Age
18 - No limit years
Sex
ALL
Healthy Volunteers
No
Heart Center, Navy General Hospital of PLA
Beijing, Beijing Municipality, China
Start Date
January 1, 2015
Primary Completion Date
June 1, 2016
Completion Date
January 1, 2017
Last Updated
July 16, 2015
30
ESTIMATED participants
remote ischemic conditioning (TDFT-12-A2)
DEVICE
Optimal medical treatment
DRUG
Lead Sponsor
Navy General Hospital, Beijing
NCT05174572
NCT04915157
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and ConditionsNCT03438500